Catalyst Wire Dossier Catalyst Wire Dossier

ATROVENT HFA

IPRATROPIUM BROMIDE · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for ATROVENT HFA, covering 2006-09-05 to 2024-12-30. Get the full timeline:

Most recent: FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing